82 related articles for article (PubMed ID: 7094567)
1. Platelet preservation with adenosine during in vitro cardiopulmonary bypass simulation.
Masters TN; Citron S; Duncan GD; Robicsek F; Born GV
Coll Works Cardiopulm Dis; 1982 May; 23():87-91. PubMed ID: 7094567
[No Abstract] [Full Text] [Related]
2. Acquired qualitative platelet disorders.
Rao AK; Walsh PN
Clin Haematol; 1983 Feb; 12(1):201-38. PubMed ID: 6340880
[No Abstract] [Full Text] [Related]
3. In vitro changes of platelet parameters: lessons from blood banking.
Rivera J; Lozano ML; Vicente V
Methods Mol Biol; 2004; 273():57-72. PubMed ID: 15308793
[No Abstract] [Full Text] [Related]
4. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
[TBL] [Abstract][Full Text] [Related]
5. Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery.
Metzelaar MJ; Korteweg J; Sixma JJ; Nieuwenhuis HK
J Lab Clin Med; 1993 Apr; 121(4):579-87. PubMed ID: 8454940
[TBL] [Abstract][Full Text] [Related]
6. Platelet function, coagulation tests, and cardiopulmonary bypass: lack of correlation between pre-operative and intra-operative whole blood lumiaggregometry and peri-operative blood loss in patients receiving autologous platelet-rich plasma.
Irani MS; Izzat NN; Jones JW
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):428-32. PubMed ID: 8589209
[TBL] [Abstract][Full Text] [Related]
7. [Preservation of platelets by freezing and its use in clinical practice].
Martínez Dalmau A
Sangre (Barc); 1985; 30(4-C):762-5. PubMed ID: 4089748
[No Abstract] [Full Text] [Related]
8. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
[TBL] [Abstract][Full Text] [Related]
9. Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass.
Addonizio VP; Macarak EJ; Niewiarowski S; Colman RW; Edmunds LH
Circ Res; 1979 Mar; 44(3):350-7. PubMed ID: 761317
[No Abstract] [Full Text] [Related]
10. Heparin, cardiopulmonary bypass, and platelet dysfunction.
Muriithi EW; Belcher PR
Artif Organs; 2006 Jun; 30(6):488-9. PubMed ID: 16734602
[No Abstract] [Full Text] [Related]
11. Platelet cryopreservation using second-messenger effector and low-dose (2%) dimethyl sulfoxide. In vitro evaluation of post-thawing platelet activity with the platelet function analyzer.
Borzini P; Lazzaro A; Mazzucco L; Schiavo R; Connor J; Siena S
Haematologica; 2000 Aug; 85(8):885-7. PubMed ID: 10942949
[No Abstract] [Full Text] [Related]
12. Autologous blood transfusion for cardiopulmonary bypass: effects of storage conditions on platelet function.
Ramnarine IR; Higgins MJ; McGarrity A; Mahmood Z; Wheatley DJ; Belcher PR
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):541-7. PubMed ID: 16884986
[TBL] [Abstract][Full Text] [Related]
13. Uncommon cold: could 4 degrees C storage improve platelet function?
Kaufman RM
Transfusion; 2005 Sep; 45(9):1407-12. PubMed ID: 16131372
[No Abstract] [Full Text] [Related]
14. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
[TBL] [Abstract][Full Text] [Related]
15. [Progress in transfusion for storage of platelets].
Cazenave JP; Isola H; Gachet C; Aleil B
Transfus Clin Biol; 2005 Jun; 12(2):226-9. PubMed ID: 15950893
[TBL] [Abstract][Full Text] [Related]
16. Blood platelets and bypass.
Edmunds LH
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):470-1. PubMed ID: 2918742
[No Abstract] [Full Text] [Related]
17. Failure of surface-modified bypass circuits to improve platelet function during pediatric cardiac surgery.
Kirshbom PM; Miller BE; Spitzer K; Easley KA; Spainhour CE; Kogon BE; Kanter KR
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):675-80. PubMed ID: 16935126
[TBL] [Abstract][Full Text] [Related]
18. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
[TBL] [Abstract][Full Text] [Related]
20. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
